NCT01245543 - Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors | Biotech Hunter

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions

Solid Tumors

Interventions

DRUG

AC480IV

AC480IV will be administered as an infusion using a dose escalation design.

DRUG

Docetaxel

Docetaxel will be administered intravenously, initially as monotherapy and subsequently in combination with docetaxel immediately following AC480IV administration.

Trial Locations (2)

78229

South Texas Accelerated Research Therapeutics (START), San Antonio

94118

University of California San Francisco (UCSF), San Francisco